Lukas C. Heukamp
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 25
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 12
- Lung Cancer Research Studies 12
-
- Lung Cancer Treatments and Mutations 60
- Lung Cancer Diagnosis and Treatment 11
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 19
- Immunology top 5%
-
- Bladder and Urothelial Cancer Treatments 12
-
- Neuroblastoma Research and Treatments 11
- Co-authors
- Jörg EllingerStefan C. MüllerPatrick J. BastianReinhard BuettnerAlexander von RueckerPhilip KahlReinhard BüttnerSebastian Rogenhofer
- Journals
- Cell (1 paper)Journal of Clinical Investigation (2 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Lukas C. Heukamp
171 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 1.5k
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 3.4k
- Immunology 784
Countries citing papers authored by Lukas C. Heukamp
This map shows the geographic impact of Lukas C. Heukamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas C. Heukamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas C. Heukamp more than expected).
Fields of papers citing papers by Lukas C. Heukamp
This network shows the impact of papers produced by Lukas C. Heukamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas C. Heukamp. The network helps show where Lukas C. Heukamp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lukas C. Heukamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 12 | |
| 4 | 2020 | 10 | |
| 5 | 2018 | 0 | |
| 6 | 2017 | 2 | |
| 7 | 2016 | 19 | |
| 8 | 2016 | 131 | |
| 9 | Prädiktive PD-L1-Immunhistochemie beim nichtkleinzelligen Bronchialkarzinom. Aktueller Stand und Erfahrungen der ersten deutschen Harmonisierungsstudie | 2016 | 17 |
| 10 | 2015 | 141 | |
| 11 | 2014 | 28 | |
| 12 | 2014 | 53 | |
| 13 | 2014 | 130 | |
| 14 | 2013 | 7 | |
| 15 | 2013 | 164 | |
| 16 | 2012 | 105 | |
| 17 | 2012 | 201 | |
| 18 | ALK(F1174L) is a driving oncogene of neuroblastoma in transgenic mice | 2012 | 1 |
| 19 | Pharmacological activation of the p53 pathway by nutlin-3 inhibits medulloblastoma cell proliferation in vitro and in vivo | 2011 | 1 |
| 20 | 2000 | 38 |
About Lukas C. Heukamp
Lukas C. Heukamp is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 175 papers that have together received 6.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Cancer Genomics and Diagnostics (25 papers), Epigenetics and DNA Methylation (19 papers), Colorectal Cancer Treatments and Studies (12 papers), Bladder and Urothelial Cancer Treatments (12 papers), Lung Cancer Research Studies (12 papers), Neuroblastoma Research and Treatments (11 papers) and Lung Cancer Diagnosis and Treatment (11 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.9k citations) and Pulmonary and Respiratory Medicine (1.7k citations). Lukas C. Heukamp has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Jörg Ellinger, Stefan C. Müller, Patrick J. Bastian, Reinhard Buettner, Alexander von Ruecker, Philip Kahl, Reinhard Büttner, Sebastian Rogenhofer, Johannes H. Schulte and Angelika Eggert. Their work appears in journals such as Cell, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.